Various specific markers (clusters of differentiation), including CD44 and CD133, have been employed for the isolation and characterization of ovarian CSCs from ovarian cancer cell lines and patients’ tumors [6,7,8,9]. Here, PROM1 is linked to ovarian carcinoma.